When two investigators needed support for their inpatient clinical trial, they turned to the ITHS Inpatient Research Activity Support program for research nurses who can go directly to inpatient units at UWMC. ...
Early-career biomedical investigators face numerous challenges when trying to become independently established. Mitigating two of the biggest challenges to becoming established is the goal of the ITHS KL2 training program, which recently accepted its newest cohort of three scholars....
Two new devices developed at the University of Washington would allow doctors to move and fragment kidney stones using ultrasound. Learn how ITHS helped take the device from idea to clinical trial....
Have you ever wanted to customize your surveys to reflect the branding of your organization? If so, you will be interested in the new survey theme functionality that has been added to REDCap....
In this question and answer piece, Gene and Cell Therapy Lab Manager Donovan Farris discusses his work at ITHS and why he is excited about the future of gene and cell therapy....
The ITHS Pediatric Clinical Research Center is a key collaborator in clinical trials of the Viaskin Peanut patch. Earlier studies have shown that the skin patch can help allergy sufferers increase their tolerance to peanuts. ...
From recruitment strategies to mobile health to lifesaving products, we have written about some amazing people, research, and discoveries this year. Read our top stories from 2015....
ITHS announced today that it will close its bionutrition research kitchen and body composition and exercise laboratory, which are located in the University of Washington Medical Center, on May 31, 2016. Nutrition and metabolism studies will be transferred from that facility to the Fred Hutchinson...
Findings from an ITHS study were used to support a new article in the Clinical and Translational Health Sciences journal that explores the barriers and accelerators to clinical study recruitment in the Pacific Northwest. ...
Dr. Julie Park, an attending physician at Seattle Children’s, is leading the effort to treat neuroblastoma through T cell therapy. Learn how an ITHS biostatistician is playing a key role in this Phase I trial....
